Akari Therapeutics Plc Quarterly Return On Equity in % from Q3 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Akari Therapeutics Plc quarterly/annual Return On Equity history and growth rate from Q3 2015 to Q3 2024.
  • Akari Therapeutics Plc Return On Equity for the quarter ending September 30, 2024 was 648 %.
  • Akari Therapeutics Plc annual Return On Equity for 2023 was -550 %.
  • Akari Therapeutics Plc annual Return On Equity for 2020 was -267 %, a 59.5% increase from 2019.
  • Akari Therapeutics Plc annual Return On Equity for 2019 was -660 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 648 Jul 1, 2024 Sep 30, 2024
Q2 2024 1.26K Apr 1, 2024 Jun 30, 2024
Q1 2024 9.84K Jan 1, 2024 Mar 31, 2024
Q4 2023 -550 Oct 1, 2023 Dec 31, 2023
Q4 2020 -267 +393 +59.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -447 Jul 1, 2020 Sep 30, 2020
Q2 2020 -620 Apr 1, 2020 Jun 30, 2020
Q1 2020 -945 Jan 1, 2020 Mar 31, 2020
Q4 2019 -660 Oct 1, 2019 Dec 31, 2019
Q2 2016 -117 Apr 1, 2016 Jun 30, 2016
Q1 2016 -136 Jan 1, 2016 Mar 31, 2016
Q4 2015 -194 Oct 1, 2015 Dec 31, 2015
Q3 2015 -420 Jul 1, 2015 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.